EcoDrugPlus

Integrin Subunit Beta 6

Ensembl ID : ENSACLG00000021596
Gene Symbol: ITGB6
1 Cross references
205 Possible Orthologues:

Integrin Subunit Beta 8

Ensembl ID : ENSACLG00000022235
Gene Symbol: ITGB8
3 Cross references
207 Possible Orthologues:

Interleukin 1 Receptor Associated Kinase 4

Ensembl ID : ENSACLG00000000097
Gene Symbol: IRAK4
3 Cross references
202 Possible Orthologues:

Intermediate Conductance Calcium-Activated Potassium Channel Protein 4-Like

Ensembl ID : ENSACLG00000025831
Gene Symbol: LOC113031849
2 Cross references
190 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 1

Ensembl ID : ENSACLG00000010612
Gene Symbol: IDH1
1 Cross references
227 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 1

Ensembl ID : ENSACLG00000010579
Gene Symbol: IDH1
1 Cross references
232 Possible Orthologues:

Isocitrate Dehydrogenase [Nadp], Mitochondrial

Ensembl ID : ENSACLG00000020847
Gene Symbol: LOC113026812
3 Cross references
196 Possible Orthologues:

Isocitrate Dehydrogenase [Nadp], Mitochondrial-Like

Ensembl ID : ENSACLG00000013584
Gene Symbol: LOC113024974
3 Cross references
204 Possible Orthologues:

Kelch Like Ech Associated Protein 1

Ensembl ID : ENSACLG00000007822
Gene Symbol: KEAP1
3 Cross references
189 Possible Orthologues:

Kinase Insert Domain Receptor

Ensembl ID : ENSACLG00000015795
Gene Symbol: KDR
3 Cross references
198 Possible Orthologues:

Kinesin Family Member 11

Ensembl ID : ENSACLG00000001740
Gene Symbol: KIF11
1 Cross references
202 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSACLG00000009432
Gene Symbol: KIF5B
4 Cross references
243 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).